Literature DB >> 28230921

Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma.

Kai-Ping Chang1,2,3, Chun-I Wang1, Curtis R Pickering4, Yenlin Huang5, Chi-Neu Tsai6, Ngan-Ming Tsang7, Huang-Kai Kao8,3, Ming-Huei Cheng8,3, Jeffrey N Myers4.   

Abstract

BACKGROUND: Mutations in the human telomerase reverse transcriptase (TERT) promoter contribute to increased TERT activity. The purpose of the present study was to assess the prevalence of TERT promoter mutations in oral cavity squamous cell carcinoma (SCC).
METHODS: Total DNA was extracted from 201 oral cavity SCC tumors and adjacent normal tissues. Primers were used to amplify the sequence region containing 2 TERT promoter mutations (C228T and C250T) that were then sequenced using the Sanger method.
RESULTS: Sequencing revealed that 52.5% (104/201) and 12.9% (26/201) of oral cavity SCC tumor tissues and 6.0% (12/201) and 2.5% (5/201) of adjacent normal tissues contained C228T and C250T mutations, respectively. In addition, the C228T mutation was significantly associated with betel nut chewing.
CONCLUSION: Our results show that mutations in the TERT promoter occur in patients with oral cavity SCC at a high frequency. This suggests that somatic TERT promoter mutations could play a vital role in the pathogenesis and progression of oral cavity SCC.
© 2017 Wiley Periodicals, Inc. Head Neck 39: 1131-1137, 2017. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  mutation; oral cavity squamous cell carcinoma; promoter; telomerase reverse transcriptase; telomere

Mesh:

Substances:

Year:  2017        PMID: 28230921     DOI: 10.1002/hed.24728

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  14 in total

1.  Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.

Authors:  Shilpa Bhatia; Jaspreet Sharma; Sanjana Bukkapatnam; Ayman Oweida; Shelby Lennon; Andy Phan; Dallin Milner; Nomin Uyanga; Antonio Jimeno; David Raben; Hilary Somerset; Lynn Heasley; Sana D Karam
Journal:  Clin Cancer Res       Date:  2018-05-30       Impact factor: 12.531

Review 2.  Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?

Authors:  Martine Froukje van der Kamp; Gyorgy Bela Halmos; Victor Guryev; Peter Laszlo Horvatovich; Ed Schuuring; Bernardus Franciscus Augustinus Maria van der Laan; Bert van der Vegt; Boudewijn Evert Christiaan Plaat; Cornelia Johanna Verhoeven
Journal:  Cell Oncol (Dordr)       Date:  2022-01-11       Impact factor: 6.730

3.  Head and Neck Cancer Stage at Presentation and Survival Outcomes Among Native Hawaiian and Other Pacific Islander Patients Compared With Asian and White Patients.

Authors:  Peter Kim Moon; Yifei Ma; Uchechukwu C Megwalu
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2022-07-01       Impact factor: 8.961

4.  Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing.

Authors:  Zhen-Fang DU; Peng-Fei Li; Jian-Qiang Zhao; Zhi-Lie Cao; Feng Li; Ju-Ming Ma; Xiao-Ping Qi
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

5.  TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.

Authors:  Paolo Boscolo-Rizzo; Silvia Giunco; Enrica Rampazzo; Martina Brutti; Giacomo Spinato; Anna Menegaldo; Marco Stellin; Monica Mantovani; Luigia Bandolin; Marco Rossi; Annarosa Del Mistro; Giancarlo Tirelli; Angelo Paolo Dei Tos; Angela Guerriero; Monia Niero; Maria Cristina Da Mosto; Jerry Polesel; Anita De Rossi
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-20       Impact factor: 4.553

6.  TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.

Authors:  Yao Yu; Dan Fan; Xinmao Song; Kaveh Zakeri; Linda Chen; Jung Kang; Sean McBride; C Jillian Tsai; Lara Dunn; Eric Sherman; Nora Katabi; Snjezana Dogan; Jennifer Cracchiolo; Marc Cohen; Jay O Boyle; Mark Lee; Cristina Valero; Jingming Wang; Richard Wong; Luc Morris; Nadeem Riaz; Nancy Lee
Journal:  JCO Precis Oncol       Date:  2021-08-05

Review 7.  Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.

Authors:  Xiaotian Yuan; Catharina Larsson; Dawei Xu
Journal:  Oncogene       Date:  2019-07-08       Impact factor: 9.867

8.  Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant.

Authors:  Elisa Majounie; Kathleen Wee; Laura M Williamson; Martin R Jones; Erin Pleasance; Howard J Lim; Cheryl Ho; Daniel J Renouf; Stephen Yip; Steven J M Jones; Marco A Marra; Janessa Laskin
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-02-03

Review 9.  Telomere Maintenance Mechanisms in Cancer.

Authors:  Tiago Bordeira Gaspar; Ana Sá; José Manuel Lopes; Manuel Sobrinho-Simões; Paula Soares; João Vinagre
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

10.  Telomere-related Markers for Cancer.

Authors:  Xiaotian Yuan; Mingkai Dai; Dawei Xu
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.